Dr. Mohsen Ahmadi is a Senior Scientist at the Leibniz Institute for Plasma Science and Technology (INP) in Greifswald, Germany. His research focuses on plasma medicine, redox biology, reactive oxygen and nitrogen species (ROS/RNS), oxidative drug modification, and redox-controlled drug and prodrug activation. A particular emphasis of his work is the mechanistic characterization of reactive species-driven chemical transformations using advanced analytical approaches, including LC–MS/MS and high-resolution mass spectrometry.
His research bridges plasma chemistry, pharmaceutical science, and translational biomedical applications, with interests ranging from cancer therapy and redox-responsive therapeutics to oxidative post-translational modifications and reaction-based redox pharmacology. He is also actively involved in research data management and FAIR data practices for biomedical and bioimaging research.
His broader scientific aim is to better understand how reactive species can be controlled and translated from complex chemical environments into predictable biological and therapeutic effects.
Dr. Mohsen Ahmadi is a Senior Scientist at the Leibniz Institute for Plasma Science and Technology (INP) in Greifswald, Germany. His research focuses on plasma medicine, redox biology, reactive oxygen and nitrogen species (ROS/RNS), oxidative drug modification, and redox-controlled drug and prodrug activation. A particular emphasis of his work is the mechanistic characterization of reactive species-driven chemical transformations using advanced analytical approaches, including LC–MS/MS and high-resolution mass spectrometry.
His research bridges plasma chemistry, pharmaceutical science, and translational biomedical applications, with interests ranging from cancer therapy and redox-responsive therapeutics to oxidative post-translational modifications and reaction-based redox pharmacology. He is also actively involved in research data management and FAIR data practices for biomedical and bioimaging research.
His broader scientific aim is to better understand how reactive species can be controlled and translated from complex chemical environments into predictable biological and therapeutic effects.